Boules M, Li Z, Smith K, Fredrickson P, Richelson E
Front Endocrinol (Lausanne). 2013; 4:36.
PMID: 23526754
PMC: 3605594.
DOI: 10.3389/fendo.2013.00036.
Smith K, Boules M, Williams K, Fauq A, Richelson E
Behav Brain Res. 2011; 224(2):344-9.
PMID: 21718721
PMC: 3159772.
DOI: 10.1016/j.bbr.2011.06.014.
St-Gelais F, Jomphe C, Trudeau L
J Psychiatry Neurosci. 2006; 31(4):229-45.
PMID: 16862241
PMC: 1488904.
St-Gelais F, Legault M, Bourque M, Rompre P, Trudeau L
J Neurosci. 2004; 24(10):2566-74.
PMID: 15014132
PMC: 6729478.
DOI: 10.1523/JNEUROSCI.5376-03.2004.
Lopez Ordieres M, Rodriguez de Lores Arnaiz G
Neurochem Res. 2003; 27(11):1555-61.
PMID: 12512960
DOI: 10.1023/a:1021612825025.
Correlative ultrastructural distribution of neurotensin receptor proteins and binding sites in the rat substantia nigra.
Boudin H, Pelaprat D, Rostene W, Pickel V, Beaudet A
J Neurosci. 1998; 18(20):8473-84.
PMID: 9763490
PMC: 6792847.
Neurotensin inhibition of the hyperpolarization-activated cation current (Ih) in the rat substantia nigra pars compacta implicates the protein kinase C pathway.
Cathala L, Paupardin-Tritsch D
J Physiol. 1997; 503 ( Pt 1):87-97.
PMID: 9288677
PMC: 1159889.
DOI: 10.1111/j.1469-7793.1997.087bi.x.
Neurotensin excites basal forebrain cholinergic neurons: ionic and signal-transduction mechanisms.
Farkas R, Nakajima S, Nakajima Y
Proc Natl Acad Sci U S A. 1994; 91(7):2853-7.
PMID: 8146199
PMC: 43469.
DOI: 10.1073/pnas.91.7.2853.
Neurotensin excitation of rat ventral tegmental neurones.
Jiang Z, Pessia M, North R
J Physiol. 1994; 474(1):119-29.
PMID: 8014889
PMC: 1160300.
DOI: 10.1113/jphysiol.1994.sp020007.
Blockade of neurotensin-induced motor activity by inhibition of protein kinase.
Kalivas P
Psychopharmacology (Berl). 1994; 114(1):175-80.
PMID: 7846201
DOI: 10.1007/BF02245461.
Treatment of PC12 cells by nerve growth factor, dexamethasone, and forskolin. Effects on cell morphology and expression of neurotensin and tyrosine hydroxylase.
Caillaud T, Opstal W, Scarceriaux V, Billardon C, Rostene W
Mol Neurobiol. 1995; 10(2-3):105-14.
PMID: 7576302
DOI: 10.1007/BF02740670.
Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain.
Seroogy K, Mehta A, Fallon J
Exp Brain Res. 1987; 68(2):277-89.
PMID: 3319664
DOI: 10.1007/BF00248793.
The electrophysiological effects of neurotensin on neurones of guinea-pig prevertebral sympathetic ganglia.
Stapelfeldt W, Szurszewski J
J Physiol. 1989; 411:301-23.
PMID: 2575666
PMC: 1190526.
DOI: 10.1113/jphysiol.1989.sp017575.
Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding.
Kelley A, Cador M, Stinus L, Le Moal M
Psychopharmacology (Berl). 1989; 97(2):243-52.
PMID: 2471221
DOI: 10.1007/BF00442258.
Comparative investigations on the actions of ACTH1-24, somatostatin, neurotensin, substance P and vasopressin on locus coeruleus neuronal activity in vitro.
Olpe H, Steinmann M, Pozza M, Haas H
Naunyn Schmiedebergs Arch Pharmacol. 1987; 336(4):434-7.
PMID: 2448659
DOI: 10.1007/BF00164879.
Dopamine and conditioned reinforcement. II. Contrasting effects of amphetamine microinjection into the nucleus accumbens with peptide microinjection into the ventral tegmental area.
Kelley A, Delfs J
Psychopharmacology (Berl). 1991; 103(2):197-203.
PMID: 1709289
DOI: 10.1007/BF02244203.
The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
Keegan K, Woodruff G, Pinnock R
Br J Pharmacol. 1992; 105(1):3-5.
PMID: 1375857
PMC: 1908621.
DOI: 10.1111/j.1476-5381.1992.tb14199.x.
Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test.
Cervo L, Rossi C, Tatarczynska E, Samanin R
Psychopharmacology (Berl). 1992; 109(3):369-72.
PMID: 1365637
DOI: 10.1007/BF02245885.